Literature DB >> 27484835

Tumor microenvironment-responsive micelles for pinpointed intracellular release of doxorubicin and enhanced anti-cancer efficiency.

Wei-Liang Chen1, Shu-di Yang1, Fang Li1, Ji-Zhao Li1, Zhi-Qiang Yuan1, Wen-Jing Zhu1, Yang Liu1, Xiao-Feng Zhou2, Chun Liu3, Xue-Nong Zhang4.   

Abstract

Internal stimuli, such as intracellular lysosomal pH, enzyme, redox and reduction, can be applied to improve biological specificity of chemotherapeutic drugs for cancer therapy. Thus, functionalized copolymers based on their response to specific microenvironment of tumor regions have been designed as smart drug vesicles for enhanced anti-cancer efficiency and reduced side effects. Herein, we reported dually pH/reduction-responsive novel micelles based on self-assembly of carboxymethyl chitosan-cysteamine-N-acetyl histidine (CMCH-SS-NA) and doxorubicin (DOX). The tailor-made dually responsive micelles demonstrated favorable stability in normal physiological environment and triggered rapid drug release in acidic and/or reduction environment. Additionally, the nanocarriers responded to the intracellular environment in an ultra-fast manner within several minutes, which led to the pinpointed release of DOX in tumor cells effectively and ensured higher DOX concentrations within tumor areas with the aid of targeted delivery, thereby leading to enhanced tumor ablation. Thus, this approach with sharp drug release behavior represented a versatile strategy to provide a promising paradigm for cancer therapy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Doxorubicin; Intracellular release; Micelles; Tumor microenvironment-responsive; Tumor-targeting therapy

Mesh:

Substances:

Year:  2016        PMID: 27484835     DOI: 10.1016/j.ijpharm.2016.07.060

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Inhibiting PI3 kinase-γ in both myeloid and plasma cells remodels the suppressive tumor microenvironment in desmoplastic tumors.

Authors:  Xueqiong Zhang; Limei Shen; Qi Liu; Lin Hou; Leaf Huang
Journal:  J Control Release       Date:  2019-07-29       Impact factor: 9.776

2.  Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma.

Authors:  Chenxi Qu; Jizhao Li; Yejuan Zhou; Shudi Yang; Weiliang Chen; Fang Li; Bengang You; Yang Liu; Xuenong Zhang
Journal:  AAPS J       Date:  2018-02-23       Impact factor: 4.009

3.  Effective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicelles.

Authors:  YueLong Wang; Min Wu; Lei Gu; XiaoLing Li; Jun He; LiangXue Zhou; Aiping Tong; Juan Shi; HongYan Zhu; JianGuo Xu; Gang Guo
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.

Authors:  Wen-Jing Zhu; Shu-di Yang; Chen-Xi Qu; Qiao-Ling Zhu; Wei-Liang Chen; Fang Li; Zhi-Qiang Yuan; Yang Liu; Ben-Gang You; Xue-Nong Zhang
Journal:  Int J Nanomedicine       Date:  2017-04-26

5.  Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury.

Authors:  JingLun Li; JiaoJiao Deng; JinXian Yuan; Jie Fu; XiaoLing Li; AiPing Tong; YueLong Wang; YangMei Chen; Gang Guo
Journal:  Int J Nanomedicine       Date:  2017-03-29

6.  Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues.

Authors:  Hao-Yan Huang; Li-Qing Chen; Wei Sun; Huan-Huan Du; Shunli Dong; Atef Mohammed Qasem Ahmed; Dingyun Cao; Jing-Hao Cui; Yi Zhang; Qing-Ri Cao
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

7.  A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.

Authors:  Weiyong Hong; Fangyuan Guo; Nan Yu; Sanjun Ying; Bang Lou; Jiangqing Wu; Ying Gao; Xugang Ji; Haiying Wang; Aiqin Li; Guoping Wang; Gensheng Yang
Journal:  Drug Des Devel Ther       Date:  2021-06-30       Impact factor: 4.162

8.  PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.

Authors:  Fangyuan Guo; Jiangqing Wu; Wenchao Wu; Dongxue Huang; Qinying Yan; Qingliang Yang; Ying Gao; Gensheng Yang
Journal:  J Nanobiotechnology       Date:  2018-07-16       Impact factor: 10.435

Review 9.  Drug Delivery Based on Stimuli-Responsive Injectable Hydrogels for Breast Cancer Therapy: A Review.

Authors:  Hai Xin; Sina Naficy
Journal:  Gels       Date:  2022-01-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.